sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 126-150 out of 1408.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>

Public Release: 28-Aug-2017
ESC Congress 2017
Apixaban lowers stroke risk in AF patients undergoing cardioversion (EMANATE)
Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups.
Pfizer, Bristol-Myers Squibb

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Lancet
Education and feedback improve use of stroke prevention drugs in AF (IMPACT-AF)
Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF trial presented today in a Hot Line LBCT Session at ESC Congress1 and published in the Lancet.
Boehringer Ingelheim Pharmaceuticals Inc., Daiichi Sankyo, Bayer Pharmaceuticals, Bristol-Myers Squibb, Pfizer Inc.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Inclisiran lowers 'bad' cholesterol for up to 1 year (ORION 1)
Inclisiran lowers low-density lipoprotein (LDL; 'bad') cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
The Medicines Company

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
The Lancet
Renal denervation lowers blood pressure in hypertensive patients
Renal denervation lowers blood pressure in hypertensive patients not taking medication, according to late-breaking results from the SPYRAL HTN-OFF MED study presented today in a Hot Line LBCT Session at ESC Congress and published in the Lancet.
Medtronic

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Lancet
Screening for vascular disease saves one life for every 169 patients assessed (VIVA)
A novel screening program for vascular disease saves one life for every 169 men assessed, according to late-breaking results from the VIVA trial presented today in a Hot Line LBCT Session at ESC Congress and published in the Lancet. The combined screening for abdominal aortic aneurysm, peripheral artery disease, and hypertension gained more living years for lower costs than European cancer screening programs.
European Union, Central Denmark Region, Danish Independent Research Council, Regional Hospital of Viborg

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
Nature Communications
Worm infection reveals cross-talk in the lymph nodes
By studying a worm infection, EPFL scientists have discovered how lymphatic vessels grow within lymph nodes, with major implications for cancer and inflammation.
Leenaards Foundation

Contact: Nik Papageorgiou
n.papageorgiou@epfl.ch
41-216-932-105
Ecole Polytechnique Fédérale de Lausanne

Public Release: 28-Aug-2017
ESC Congress 2017
16-year study suggests air temperature is external trigger for heart attack
A 16-year study in more than 280,000 patients has suggested that air temperature is an external trigger for heart attack. The findings are presented today at ESC Congress.
Swedish Heart and Lung Foundation, Swedish Scientific Research Council, SSF, Knut and Alice Wallenbergs Foundation, ALF, Skane University Hospital

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Study suggests statins associated with lower rates of breast cancer and mortality
A 14 year study in more than one million people has found that women with high cholesterol have significantly lower rates of breast cancer and improved mortality. The research, presented today at ESC Congress, suggests that statins are associated with lower rates of breast cancer and subsequent mortality.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Transcatheter aortic valve implantation safe and effective in nonagenarians
Transcatheter aortic valve implantation (TAVI) is safe and effective in nonagenarians, according to research presented at ESC Congress today.1 The observational study found that nonagenarians who underwent TAVI had worse short-term outcomes but similar one-year outcomes as patients younger than 90 years.
Brazilian Society of Interventional Cardiology

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
PCSK9 inhibition could ameliorate cardiovascular disease by immune mechanisms
PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to research presented today at ESC Congress.
Swedish Heart Lung Foundation, Swedish Research Council, Stockholm County, King Gustav V 80th Birthday Fund, Swedish Association against Rheumatism, Vinnova, AFA, Torsten Söderberg's Foundation

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Married patients with heart disease have better survival rates
Marriage is a vital factor affecting the survival of patients who have had a heart attack, as well as the survival of patients with the most important risk factors, according to research presented today at ESC Congress.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
New England Journal of Medicine
Drug cuts cardiovascular disease and lung cancer risk by reducing inflammation (CANTOS)
The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line -- LBT Session at ESC Congress1 and published in the NEJM.
Novartis

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Catheter ablation improves outcomes in patients with heart failure and AF (CASTLE-A)
Catheter ablation improves outcomes for patients with left ventricular dysfunction and atrial fibrillation, according to late-breaking results from the CASTLE-AF trial presented today in a Hot Line -- LBCT Session at ESC Congress.1 Patients who received catheter ablation of atrial fibrillation had lower mortality and less hospitalisation for worsening heart failure compared to those receiving conventional drug treatment.
Biotronik GmbH

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
New England Journal of Medicine
Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)
Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in the NEJM.
Bayer AG

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Rivaroxaban plus aspirin reduces adverse events (COMPASS)
Rivaroxaban plus aspirin reduces major adverse cardiovascular and limb events by nearly one-third in patients with peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line -- LBCT Session at ESC Congress.
Bayer AG

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Risk factor driven upstream AF therapy improves sinus rhythm (RACE 3)
Risk factor driven upstream rhythm control is effective, feasible and safe in improving maintenance of sinus rhythm in patients with early short lasting atrial fibrillation (AF) and heart failure, according to late-breaking results from the RACE 3 trial presented today in a Hot Line - LBCT Session at ESC Congress.1 The novel therapy included meticulous treatment of risk factors and change of lifestyle and was superior to conventional guideline recommended rhythm control.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Automatic external defibrillators save lives in amateur sports and fitness centers
Automatic external defibrillators (AEDs) save lives in amateur sports and fitness centers, according to research presented at ESC Congress today. The 18-year study found that survival from cardiac arrest reached 93 percent in centers equipped with an AED.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Higher coffee consumption associated with lower risk of death
Higher coffee consumption is associated with a lower risk of death, according to research presented today at ESC Congress.1 The observational study in nearly 20 000 participants suggests that coffee can be part of a healthy diet in healthy people.
Instituto de Salud Carlos III, CIBER, Regional Government of Navarra

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Study confirms safety of rapid algorithm to rule-out and rule-in myocardial infarction
The safety and efficacy of a rapid algorithm to rule-out and rule-in myocardial infarction has been confirmed in a study presented at ESC Congress today.
Swiss National Science Foundation, Swiss Heart Foundation, KTI, European Union, Stiftung für kardiovaskuläre Forschung Basel, Abbott, Beckman Coulter, Biomerieux, Brahms

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis
PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis, according to research presented at ESC Congress today. The findings suggest that PCSK9 inhibitors, a new class of cholesterol-lowering treatments, may also reduce thrombosis by interfering with platelet activation.
2016 ASPIRE Cardiovascular Competitive Research Grant, Pfizer

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
High salt intake associated with doubled risk of heart failure
High salt intake is associated with a doubled risk of heart failure, according to a 12-year study in more than 4 000 people presented today at ESC Congress.
National Institute of Health and Welfare (formerly National Public Health Institute)

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC Guidelines on ST-segment elevation myocardial infarction published today
European Society of Cardiology (ESC) Guidelines on the management of acute myocardial infarction in patients with ST-segment elevation are published online today in European Heart Journal,1 and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC focused update on dual antiplatelet therapy in coronary artery disease published today
The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal,1 and on the ESC website.2 The document was developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases published today
European Society of Cardiology (ESC) Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the European Society for Vascular Surgery (ESVS), are published online today in European Heart Journal,1 European Journal of Vascular and Endovascular Surgery, and the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC/EACTS Guidelines for the management of valvular heart disease published today
European Society of Cardiology (ESC) / European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease are published online today in European Heart Journal1 and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Showing releases 126-150 out of 1408.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>